When East Meets West: Lessons From Running A Lab Filled With Foreigners

As a rare Westerner strolling recently among Shanghai’s 12 million Chinese, I nearly caused spectacular bicycle pile-ups. Riders risked life and limb to snap their heads in my direction, underlining my novel role as a minority person. Yet when I returned to my research laboratory at Emory University in Atlanta, it seemed that little had changed. True, there were no potential bike catastrophes. But my research group of eight contains just three United States citizens. The rest are from C

Written bySidney Perkowitz
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

As a rare Westerner strolling recently among Shanghai’s 12 million Chinese, I nearly caused spectacular bicycle pile-ups. Riders risked life and limb to snap their heads in my direction, underlining my novel role as a minority person. Yet when I returned to my research laboratory at Emory University in Atlanta, it seemed that little had changed. True, there were no potential bike catastrophes. But my research group of eight contains just three United States citizens. The rest are from China, Taiwan, India, and Korea.

My group mirrors an important trend, the increasing numbers of international students and professionals in U.S. science and technology, many from China and other developing "Asiatic nations. The pros and cons for the U.S. and the home countries have been widely discussed, but I haven’t heard a great deal about the impact on university research groups, where much of this country’s science is done and taught. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies